Skip to main content
EQ logo

Equillium, Inc.

EQNASDAQHealthcareBiotechnology

$1.19Today:- (-)1Y −9.59%

As of Oct 16, 2026 close

Market cap
$147.58M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.76$3.54
Volume (live)
-
Avg. volume (3M)
659.98K

Equillium (EQ) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Equillium used $22.75M of cash in operating activities and spent $48.00K on capital expenditures. That left free cash flow of −$22.79M.

Equillium Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Equillium, Inc. (EQ) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-22.40-8.07-13.34-62.43-39.05-29.81-25.60-13.25-2.26
Depreciation & Amortization0.120.140.130.120.070.050.020.010.00
Deferred Income Tax0.000.000.000.000.55-0.270.000.000.00
Stock Based Compensation2.323.754.004.844.413.822.250.440.00
Change in Working Capital-2.320.84-2.5525.101.701.260.710.300.43
Change in Accounts Receivable0.003.74-0.90-2.840.000.000.000.000.00
Change in Accounts Payable-1.94-2.000.722.51-1.580.890.780.840.00
Change in Other Working Capital-0.38-15.73-2.37-0.083.280.36-0.06-0.540.43
Other Operating Activities-0.47-15.73-10.0323.640.240.34-0.344.981.17
Net Cash from Operating Activities-22.75-19.03-21.78-8.73-32.08-24.62-22.95-7.53-0.66
Investing Activities
Capital Expenditures-0.05-0.09-0.05-0.28-0.06-0.20-0.07-0.030.00
Acquisitions0.010.000.000.700.000.000.000.000.00
Purchases of Investments0.00-17.60-54.71-14.96-32.99-55.51-54.62-37.400.00
Sales/Maturities of Investments4.5031.5050.0033.2360.4637.1252.530.000.00
Other Investing Activities0.000.000.000.700.000.000.000.000.00
Net Cash from Investing Activities4.4613.81-4.7618.6827.41-18.59-2.17-37.430.00
Financing Activities
Debt Repayment0.000.00-9.13-1.430.000.009.881.607.77
Common Stock Issued0.680.160.000.2129.9153.780.0064.480.00
Common Stock Repurchased0.000.00-0.260.000.000.00-0.160.000.00
Other Financing Activities0.000.000.170.211.150.160.110.290.00
Net Cash from Financing Activities30.430.16-9.23-1.2231.0653.959.8466.377.77
Summary
Effect of Forex Changes on Cash0.05-0.08-0.120.010.000.03-0.010.000.00
Net Change in Cash12.19-5.13-35.898.7426.3810.76-15.2921.407.10
Cash at Beginning of Period18.0923.2259.1150.3723.9813.2228.517.100.00
Cash at End of Period30.2818.0923.2259.1150.3723.9813.2228.517.10
Free Cash Flow-22.79-19.11-21.83-9.01-32.14-24.83-23.02-7.56-0.66
Supplemental Disclosures
Interest Paid--0.950.850.840.84---
Income Taxes Paid--0.58------

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Equillium Cash Flow

What is Equillium's free cash flow?

Equillium had negative free cash flow of $22.79M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$22.75M minus $48.00K of capital expenditures.

How much does Equillium spend on capital expenditures?

Equillium spent $48.00K on capital expenditures in fiscal 2025, compared with $85.00K a year earlier.

Does Equillium pay dividends or buy back shares?

Equillium's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition